Home > Publications Database > NeuroBooster Array: A Genome-Wide Genotyping Platform to Study Neurological Disorders Across Diverse Populations. > print

001     272954
005     20241126104234.0
024 7 _ |a 10.1002/mds.29902
|2 doi
024 7 _ |a pmid:39283294
|2 pmid
024 7 _ |a pmc:PMC11568947
|2 pmc
024 7 _ |a 0885-3185
|2 ISSN
024 7 _ |a 1531-8257
|2 ISSN
024 7 _ |a altmetric:168026568
|2 altmetric
037 _ _ |a DZNE-2024-01333
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Bandres-Ciga, Sara
|0 0000-0003-0056-1361
|b 0
245 _ _ |a NeuroBooster Array: A Genome-Wide Genotyping Platform to Study Neurological Disorders Across Diverse Populations.
260 _ _ |a New York, NY
|c 2024
|b Wiley
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1732005213_9133
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Commercial genome-wide genotyping arrays have historically neglected coverage of genetic variation across populations.We aimed to create a multi-ancestry genome-wide array that would include a wide range of neuro-specific genetic content to facilitate genetic research in neurological disorders across multiple ancestral groups, fostering diversity and inclusivity in research studies.We developed the Illumina NeuroBooster Array (NBA), a custom high-throughput and cost-effective platform on a backbone of 1,914,934 variants from the Infinium Global Diversity Array and added custom content comprising 95,273 variants associated with more than 70 neurological conditions or traits, and we further tested its performance on more than 2000 patient samples. This novel platform includes approximately 10,000 tagging variants to facilitate imputation and analyses of neurodegenerative disease-related genome-wide association study loci across diverse populations.In this article, we describe NBA's potential as an efficient means for researchers to assess known and novel disease genetic associations in a multi-ancestry framework. The NBA can identify rare genetic variants and accurately impute more than 15 million common variants across populations. Apart from enabling sample prioritization for further whole-genome sequencing studies, we envisage that NBA will play a pivotal role in recruitment for interventional studies in the precision medicine space.From a broader perspective, the NBA serves as a promising means to foster collaborative research endeavors in the field of neurological disorders worldwide. Ultimately, this carefully designed tool is poised to make a substantial contribution to uncovering the genetic etiology underlying these debilitating conditions. © 2024 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society. This article has been contributed to by U.S. Government employees and their work is in the public domain in the USA.
536 _ _ |a 353 - Clinical and Health Care Research (POF4-353)
|0 G:(DE-HGF)POF4-353
|c POF4-353
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
650 _ 7 |a Centre for Alzheimer's and Related Dementias
|2 Other
650 _ 7 |a Global Parkinson's Genetics Program
|2 Other
650 _ 7 |a NeuroBooster array
|2 Other
650 _ 7 |a diversity
|2 Other
650 _ 7 |a genetic screening
|2 Other
650 _ 7 |a genotyping
|2 Other
650 _ 7 |a neurological diseases
|2 Other
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Genome-Wide Association Study: methods
|2 MeSH
650 _ 2 |a Nervous System Diseases: genetics
|2 MeSH
650 _ 2 |a Genotype
|2 MeSH
650 _ 2 |a Genetic Variation: genetics
|2 MeSH
650 _ 2 |a Genotyping Techniques: methods
|2 MeSH
650 _ 2 |a Polymorphism, Single Nucleotide: genetics
|2 MeSH
650 _ 2 |a Genetic Predisposition to Disease: genetics
|2 MeSH
700 1 _ |a Faghri, Faraz
|b 1
700 1 _ |a Majounie, Elisa
|b 2
700 1 _ |a Koretsky, Mathew J
|b 3
700 1 _ |a Kim, Jeffrey
|0 0000-0003-0738-0512
|b 4
700 1 _ |a Levine, Kristin S
|b 5
700 1 _ |a Leonard, Hampton
|0 P:(DE-2719)9001970
|b 6
700 1 _ |a Makarious, Mary B
|0 0000-0002-7978-1051
|b 7
700 1 _ |a Iwaki, Hirotaka
|0 0000-0002-8982-7885
|b 8
700 1 _ |a Crea, Peter Wild
|b 9
700 1 _ |a Hernandez, Dena G
|0 P:(DE-2719)2812102
|b 10
700 1 _ |a Arepalli, Sampath
|b 11
700 1 _ |a Billingsley, Kimberley
|b 12
700 1 _ |a Lohmann, Katja
|0 P:(DE-2719)9000191
|b 13
700 1 _ |a Klein, Christine
|b 14
700 1 _ |a Lubbe, Steven J
|b 15
700 1 _ |a Jabbari, Edwin
|0 0000-0001-6844-882X
|b 16
700 1 _ |a Saffie-Awad, Paula
|b 17
700 1 _ |a Narendra, Derek
|0 0000-0002-8696-9108
|b 18
700 1 _ |a Reyes-Palomares, Armando
|b 19
700 1 _ |a Quinn, John P
|b 20
700 1 _ |a Schulte, Claudia
|0 P:(DE-2719)9000366
|b 21
700 1 _ |a Morris, Huw R
|0 0000-0002-5473-3774
|b 22
700 1 _ |a Traynor, Bryan J
|b 23
700 1 _ |a Scholz, Sonja W
|0 0000-0002-6623-0429
|b 24
700 1 _ |a Houlden, Henry
|0 0000-0002-2866-7777
|b 25
700 1 _ |a Hardy, John
|b 26
700 1 _ |a Dumanis, Sonya
|b 27
700 1 _ |a Riley, Ekemini
|b 28
700 1 _ |a Blauwendraat, Cornelis
|0 P:(DE-2719)2810837
|b 29
700 1 _ |a Singleton, Andrew
|b 30
700 1 _ |a Nalls, Mike
|b 31
700 1 _ |a Jeff, Janina
|b 32
700 1 _ |a Vitale, Dan
|b 33
700 1 _ |a Alzheimer's, Global Parkinson's Genetics Program and the Center for
|b 34
|e GP2
700 1 _ |a Dementias, Related
|b 35
|e Collaboration Author
773 _ _ |a 10.1002/mds.29902
|g Vol. 39, no. 11, p. 2039 - 2048
|0 PERI:(DE-600)2041249-6
|n 11
|p 2039 - 2048
|t Movement disorders
|v 39
|y 2024
|x 0885-3185
856 4 _ |y OpenAccess
|u https://pub.dzne.de/record/272954/files/DZNE-2024-01333.pdf
856 4 _ |y OpenAccess
|x pdfa
|u https://pub.dzne.de/record/272954/files/DZNE-2024-01333.pdf?subformat=pdfa
909 C O |o oai:pub.dzne.de:272954
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 21
|6 P:(DE-2719)9000366
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-353
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Clinical and Health Care Research
|x 0
914 1 _ |y 2024
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-10-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2023-10-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2023-10-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2023-10-24
915 _ _ |a Creative Commons Attribution-NonCommercial-NoDerivs CC BY-NC-ND 4.0
|0 LIC:(DE-HGF)CCBYNCND4
|2 HGFVOC
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b MOVEMENT DISORD : 2022
|d 2023-10-24
915 _ _ |a DEAL Wiley
|0 StatID:(DE-HGF)3001
|2 StatID
|d 2023-10-24
|w ger
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2023-10-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-10-24
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2023-10-24
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b MOVEMENT DISORD : 2022
|d 2023-10-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-10-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2023-10-24
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
|d 2023-10-24
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-10-24
920 1 _ |0 I:(DE-2719)1210000
|k AG Gasser
|l Parkinson Genetics
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-2719)1210000
980 1 _ |a FullTexts

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21